ACTRN12617001521314已完成1 期
A Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ACH-0145228 in Healthy Volunteers
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 25 Years 至 55 Years（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A single ascending dose study to assess the safety, tolerability and pharmacokinetics of RO5428029 in healthy male subjectsHCVHepatitis C Virus infectioninfection of the liver10047438NL-OMON34361Roche Nederland B.V.60
已完成
不适用
A Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ENX-101 at Plasma Steady State in Healthy VolunteersEpilepsyNL-OMON51175Engrail Therapeutics, Inc.53
已完成
不适用
A Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ENX-102 at Plasma Steady State in Healthy VolunteersCentral nervous system disorders10042258NL-OMON52117Engrail Therapeutics, Inc56
已完成
1 期
Healthy Volunteer, Single Ascending Dose Study of TP-317Inflammatory bowel diseaseOral and Gastrointestinal - Inflammatory bowel diseaseACTRN12624000239561Thetis Pharmaceuticals LLC24
已完成
不适用
Ascending single dose study of the safety, tolerability, and pharmacokinetics of PRM-151 administered to healthy volunteers and patients with idiopathic pulmonary fibrosis (IPF)NL-OMON33156Centre for Human Drug Research32